GreeneStone Seeks Amex Listing – New Report Confirms Demand

  GreeneStone Seeks Amex Listing – New Report Confirms Demand

Business Wire

TORONTO -- October 18, 2012

GreeneStone Healthcare Corporation (OTCBB: GRST) (“GreeneStone” or “the
Company”) announces today that it will begin the process of applying to the
New York Stock Exchange (“NYSE”) to list on the NYSE-Amex exchange. The
Company’s recent performance has brought the Company to, or near to, the
levels required to meet the listing requirements for the NYSE-Amex under its
Standard 3 definitions. It is anticipated that the Company will meet all the
requirements at the time it has completed the application process. The Company
has determined that the NYSE-Amex listing will best serve the Company’s needs
to attract capital to support its recently announced ‘build and buy’ expansion
strategy. The ‘build and buy’ expansion strategy is designed to stay ahead of
the market to take advantage of the green field opportunity in Canada and the
ever growing demand in the US in the underserviced mental healthcare sector.
The focus of the expansion strategy is to reach the 300 bed level in its
in-patient addiction treatment business in the next twenty-four months.

A recently released report has emphasized the huge demand that the Company has
identified. The report was released on October 10th, 2012 by the Institute for
Clinical Evaluation Sciences (ICES) and Public Health Ontario. The report
demonstrates that "the burden of mental illness and addictions in Ontario is
more than 1.5 times that of all cancers and more than seven times that of all
infectious diseases." The report goes on to say "five conditions have the
highest impact on the life and health of Ontarians: depression, bipolar
disorder, alcohol use disorders, social phobia and schizophrenia.” Research
has shown that mental disorders and addictions are very prevalent (e.g. one in
five Canadians will experience a mental disorder each year) and cost Canada
billions of dollars (e.g. forty to fifty billion dollars annually). This study
confirms that the burden of mental disorders and addictions is very high and
outstrips the burden of many physical illnesses. “This report does not
surprise me, the numbers are staggering”, stated Shawn Leon CEO of the
Company. “ The awareness of mental health is growing and we are set to carve
out a niche in this sector” he added. ICES is an independent, non-profit
organization that produces knowledge to enhance the effectiveness of health
care for Ontarians. The summary (6 pages) and the full report are available on
the ICES web site at

http://www.ices.on.ca/webpage.cfm?site_id=1&org_id=31&morg_id=0&gsec_id=0&item_id=7718

Follow GreeneStone Healthcare Corp. and the company's activities at the
following Facebook sites:
GreeneStone Muskoka:
https://www.facebook.com/pages/GreeneStone-Muskoka/510641255628356
GreeneStone Yorkville:
https://www.facebook.com/pages/GreeneStone-Yorkville/452197614820117

About GreeneStone Healthcare Corporation

GreeneStone is a provider of mental health services, specializing in the areas
of addiction treatment, eating disorders, nutrition and weight loss, and
executive healthcare. GreeneStone is a new company in the behavioral treatment
sector in Canada, an industry that has been well developed in the US but
remains in its early evolutionary stages in Canada. GreeneStone is among the
many nascent healthcare companies re-defining the healthcare space for the
modern economy, which include Roche Holding Ltd. (OTCQB: RHHBY), Sarepta
Therapeutics Inc. (NASDAQ: SRPT), Nektar Therapeutics (NASDAQ: NKTR), Celldex
Therapeutics, Inc. (NASDAQ: CLDX), Achillion Pharmaceuticals, Inc. (NASDAQ:
ACHN), Zogenix, Inc. (NASDAQ: ZGNX). The company operates medical and
healthcare clinics in Ontario, Canada, serving a North American and
international clientele. GreeneStone’s clinics meet several ends: (1)
GreeneStone adds overflow capacity to an increasingly stretched public
healthcare system in Canada, (2) GreeneStone mental health clinics provide
private alternatives to publicly available but highly underserviced healthcare
subsectors, and (3) GreeneStone meets newly developing healthcare needs
undisturbed by the public/private market, such as eating disorders. The
company is headquartered in Toronto, Canada.

Notice Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933 (the “Securities Act”) and Section
21E of the Securities Exchange Act of 1934 (the “Exchange Act”). To the extent
that any statements made in this press release contain information that is not
historical, these statements are essentially forward-looking. Forward-looking
statements can be identified by the use of words such as “expect,” “plan,”
“will,” “may,” “anticipate,” “believe,” “should,” “intend,” “estimate,” and
variations of such words. Forward-looking statements are subject to risks and
uncertainties that cannot be predicted or quantified and, consequently, actual
results may differ materially from those expressed or implied by such
forward-looking statements. Such risks and uncertainties include, without
limitation, those risks and uncertainties contained in this press release and
those identified in the periodic reports that the company files with the
Securities and Exchange Commission (the “SEC”) pursuant to the Exchange Act.

Investor information and email sign-up:
http://www.greenestoneinvestor.com

Contact:

GreeneStone Healthcare
Shawn Leon, 416-222-5501
investor@greenestoneinvestor.com
www.greenestoneinvestor.com
 
Press spacebar to pause and continue. Press esc to stop.